Ukoniq Lawsuits
The FDA Withdraws Approval for Ukoniq (Umbralisib). On June 1, 2022, the U.S. Food and Drug Administration (FDA) withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns. Ukoniq had been approved to treat marginal zone lymphoma (MZL) and follicular lymphoma (FL). According to the FDA, the risks … [Read more...] about Ukoniq Lawsuits
Ukoniq Lawsuits
The FDA Withdraws Approval for Ukoniq (Umbralisib). On June 1, 2022, the U.S. Food and Drug Administration (FDA) withdrew its approval for the cancer medicine Ukoniq (umbralisib) due to safety concerns. Ukoniq had been approved to treat marginal zone lymphoma (MZL) and follicular lymphoma (FL). According to the FDA, the risks … [Read more...] about Ukoniq Lawsuits
Ukoniq Wrongful Death Lawsuits
On June 1, 2022, the the U.S. Food and Drug Administration (FDA) announced withdrawal of its approval for Ukoniq (umbralisib), a cancer medication previously approved to treat marginal zone lymphoma (MZL) and follicular lymphoma (FL). The FDA Ukoniq investigation continues. According to a news report posted on MedPageToday.com, … [Read more...] about Ukoniq Wrongful Death Lawsuits
